Indeed, the mutant Cbl-c binds to the EGFR and prevents the recruitment of the wild-type Cbl protein, suggesting that loss of Cbl-c is involved in cancer progression in solid tumors, both in mice and human models [161]. This evidence concerns the gene CBLC and cancer.